Page last updated: 2024-11-06

seganserin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

seganserin: MW=471.55+72.92; MF=C29-H27-F2-N3-O. 2HCL; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71767
CHEMBL ID1742436
SCHEMBL ID246745
MeSH IDM0134236

Synonyms (26)

Synonym
PDSP2_000824
seganserin
PDSP1_000837
3-[2-[4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl]ethyl]-2-methylpyrido[1,2-a]pyrimidin-4-one
cas_159037
nsc_159037
bdbm81978
4h-pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-2-methyl-, dihydrochloride
87729-89-3
CHEMBL1742436
seganserinum
seganserine
seganserina [spanish]
seganserine [french]
seganserinum [latin]
unii-197hl4ezcc
seganserina
3-(2-(4-(bis(p-fluorophenyl)methylene)piperidino)ethyl)-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-one
seganserin [inn:ban]
197hl4ezcc ,
seganserin [inn]
SCHEMBL246745
ZGUPMFYFHHSNFK-UHFFFAOYSA-N
3-[2-[4-[bis(4-fluorophenyl)methylene]-1-piperidinyl]ethyl]-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one
DTXSID50236594
Q27252077

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Pretreatment with seganserin, a 5-HT(2) receptor antagonist (2 mg/kg, i.p.) significantly reversed fluoxetine and quipazine-induced antidepressant and analgesic effects."( Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice.
Kaur, G; Kulkarni, SK, 2002
)
0.64
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (57.14)18.7374
1990's2 (28.57)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.94 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]